Premium
Understanding rare comorbidities in TAVR
Author(s) -
Block Peter C.
Publication year - 2015
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.26244
Subject(s) - medicine , valve replacement , esophageal varices , cardiology , intensive care medicine , portal hypertension , cirrhosis , stenosis
Key Points There seems to be an early morbidity and mortality advantage to TAVR in patients with chronic liver disease. Patients with Childs A and B CLD can be treated with TAVR but we know little about TAVR for sicker patients. Technical issues associated with TAVR (the use of transesophageal echocardiography (TEE) for example) have to be weighed in CLD patients with esophageal varices.